HCmed Introduces its Vibrating Mesh Nebulizer to Chung Shan Medical University Hospital

On March 3rd, HCmed hosted a lunch symposium at Chung Shan Medical University Hospital. During the event, we introduced our Pulmogine vibrating mesh nebulizer to pediatricians and nursing staff at the medical center.

HCmed's Pulmogine Nebulizer Receives FDA Approval for Use with Pulmozyme

HCmed is proud to announce that our Pulmogine Vibrating Mesh Nebulizer has been approved by the U.S. Food and Drug Administration (FDA) for use with Pulmozyme, a widely prescribed medication for cystic fibrosis patients.

HCmed Innovations' CEO Outlines New Year Resolutions for 2024

As HCmed Innovations celebrates its 10th year in operation, our CEO, Jason Cheng, has unveiled a bold set of New Year resolutions aimed at propelling the organization to new heights.

First look at HCmed UK!

We're excited to unveil our new HCmed UK site, located in Chichester, West Sussex UK.

HCmed Appoints New Chief Scientific Officer

HCmed announced the appointment of Gunilla Petersson, Ph.D. as the new Chief Scientific Officer (CSO).

Interview with HCmed's Co-founder and Pediatrician, Dr. Shao Chi Huang

Dr. Shao Chi Huang this month shares his experience working in the clinical field.

HCmed Innovations Prepares to Register in the Taiwan Emerging Stock Market

HCmed Innovations Co., Ltd. (6934) is pleased to announce that it has recently become a public company in Taiwan.

Interview with HCmed's Chief Executive Officer and Founder, Jason Cheng

Chief Executive Officer (CEO) and founder of HCmed, Jason Cheng this week shares his experience founding and managing HCmed Innovations.

Interview with HCmed's Finance and Accounting Manager, Wooca Tu

Finance and Accounting Manager of the Management Department at HCmed Innovations, Wooca Tu, this week shares his working experience and management goals at HCmed.

Interview with HCmed's Manufacturing Department Director, Chester Lin

As the Director of the Manufacturing Department at HCmed Innovations, Chester Lin leads the department on plant design, management and production, aiming to improve production and efficiency whilst reducing waste and costs .

Interview with HCmed's Regulatory Affairs Manager, Michelle Pieh

Michelle Pieh shares her experience leading the regulatory affairs and quality assurance teams at HCmed.

Pulmogine Is Included in the Australian Register of Therapeutic Goods (ARTG)

Pulmogine, a vibrating mesh nebulizer developed by HCmed, has been included in the Australian Register of Therapeutic Goods (ARTG) since April 2022.

Interview with HCmed's BD Director, Connie Chen

Director of Business Department at HCmed Innovations, Connie Chen this month shares her experience and thoughts working in the biomedical industry.

Interview with HCmed's Project Manager, Ellie Chen

As the head of the Project Management Department, Ellie Chen this week shares her experience working at HCmed Innovations Co., Ltd.

Interview with HCmed's BD Manager & Scientist, Hernan Cuevas Brun

Hernan Cuevas Brun, Business Development Manager and Aerosol Drug Delivery Scientist at HCmed Innovations, this week shares his experience working in the industry of developing nebulizers and combination products.

Interview with HCmed's R&D Director, Yuan-Ming Hsu

This week Yuan-Ming Hsu, Director of the R&D Department at HCmed Innovations, shares his thoughts and experience working in the medical device industry.

Interview with HCmed's COO, Leon Tsai

HCmed's COO, Leon Tsai, shares his experience in the development of mesh nebulizer and his motivation to improve these devices to provide more effective solutions for inhalation therapy.

HCmed and Cellics Announce Collaboration on Nebulized Nanosponges for the Treatment of Bacterial Infections and Inflammatory Diseases

HCmed Innovations Co., Ltd. (HCmed) and Cellics Therapeutics, Inc. (Cellics) have initiated a collaboration, introducing inhalation therapy for the delivery of nanospages.

HCmed Wins 2021 Taiwan BIO Award for Growth Potential

HCmed Innovations Co., Ltd. (HCmed) is honored to be listed as one the winners awarded for its growth potential.

HCmed Receives FDA 510(k) Approval for Pulmogine

HCmed Innovations is delighted to announce that it has received US Food and Drug Administration (FDA) 510(k) clearance for its portable mesh nebulizer, Pulmogine.

HCmed Signs Agreement With Cathay For IPO

HCmed Innovations (HCmed) signed an agreement with Cathay Securities on June 21st, 2021, to prepare for its initial public offering (IPO).

HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring

Companies Initiated Phase I trial in December 2020

HCmed Joins the 3rd China International Import Expo (CIIE)

In its second consecutive year showcasing as an invited guest of I-Campus at the CIIE, HCmed Innovations was delighted to introduce its new smart device prototype

Pulmogine Vibrating Mesh Nebulizer is now available in China

We are delighted to announce that SinoMedCare BioTech Co., Ltd. (SMC) has become the exclusive distributor of our vibrating mesh nebulizer Pulmogine in China.

HCmed Innovations Co., Ltd. is committed to help in the fight against the COVID-19 pandemic

HCmed is ready to join the fight. Our mesh nebulizers are highly efficient customizable devices that deliver drugs deep into the lungs.

HCmed’s Pulmogine Mesh Nebulizer receives NMPA Approval

HCmed Innovations is pleased to inform that it has received NMPA approval from the National Medical Products Administration in China for its handheld mesh nebulizer, Pulmogine.

HCmed’s Pulmogine Mesh Nebulizer receives NMPA Approval

HCmed Innovations is pleased to inform that it has received NMPA approval from the National Medical Products Administration in China for its handheld mesh nebulizer, Pulmogine.

HCmed Joins the China International Import Expo and China Healthcare Summit

Aiming to continue expanding its global presence and promoting its new brand “Pulmogine,” HCmed Innovations participated at two main events held in China this month.

HCmed introduces Pulmogine in the 2019 ERS Congress

HCmed Innovations Co., Ltd., presented its latest brand, Pulmogine, in the 2019 ERS International Congress.

HCmed Innovations joins Wuxi International Life Science Innovation Park supported by AstraZeneca China

HCmed Innovations Co., Ltd. (HCmed) has been selected as the first batch companies to join Wuxi International Life Science Innovation Park.

Deepro Vibrating Mesh Nebulizer is now available in Brazil

HCmed Innovations Co., Ltd., in collaboration with one of the world's top 10 pharmaceutical companies, has officially launched its vibrating mesh nebulizer, Deepro, in the Federative Republic of Brazil.

Vivo Capital Strategic Investment through PANDA Fund, L.P. Supporting HCmed Innovations for Global Strategic Expansion in Mobile Nebulizer Markets

HCmed Innovations (HCmed) confirmed on December 27, 2017, that Vivo capital, through the fund under its management, PANDA Fund, L.P., has become its strategic investor.

Celebrating Deepro’s New Arrival: Delightful to Go

Deepro is ready to blow your mind by its incredibly chic look and superior performance!

Thank You for Visiting HCMedi’s at ERS 2016 in London

As inquiries regarding Deepro keep increasing, HCMedi thirsts for more conversations.

The Only IP55 Water Resistant Nebulizer in The World!

No more worries about medication leakage during nebulization. Register now to join the delightful experience with us, and win a free gift.

Vibrating mesh nebulier: A Modern Approach to Asthma and COPD Treatment

Nebulization is a time-tested approach for delivering aerosol to targeted pulmonary areas, especially for inhalation therapies that require deep lung deposition.

An Easy Nebulizer for a Better Aerosol Delivery

The principle of nebulizer therapy can be tracked as far back as 4000 years ago. Since the earliest days of recorded human history, people have been suffering from throat and chest pains.

The Suitable Device for a Correct Inhalation Is the Key of Asthma Management

The number of people suffering from asthma has exploded since the 1970s and continues to grow every year.